Evidence map›Paper›PMID 36620804›Full record

ArticleCureus2022

BRASH Syndrome Presenting With Idioventricular Escape Rhythm in a Patient With Trifascicular Block.

Henry O Aiwuyo, Nosakhare P Ilerhunmwuwa, Narek Hakobyan, Ephrem Sedeta, Ifeanyi Uche, Mustafa Wasifuddin, Beatrice E Torere, Jamal C Perry, Shahrokh E Rafii

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Cureus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Henry O AiwuyoInternal Medicine, Brookdale University Hospital Medical Center, Brooklyn, USA.
Nosakhare P IlerhunmwuwaInternal Medicine, Brookdale University Hospital Medical Center, Brooklyn, USA.
Narek HakobyanInternal Medicine, Saba University School of Medicine, Brooklyn, USA.
Ephrem SedetaInternal Medicine, Brookdale University Hospital Medical Center, Brooklyn, USA.
Ifeanyi UcheInternal Medicine, Brookdale University Hospital Medical Center, Brooklyn, USA.
Mustafa WasifuddinInternal Medicine, Brookdale University Hospital Medical Center, Brooklyn, USA.
Beatrice E TorereInternal Medicine, North Mississippi Medical Center, Tupelo, USA.
Jamal C PerryMedicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Shahrokh E RafiiCardiology, Brookdale University Hospital Medical Center, Brooklyn, USA.
North Mississippi Medical Center · USCalifornia Institute of Behavioral Neurosciences and Psychology (United States) · USSaba University · YE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bradycardia, renal failure, atrioventricular (AV) nodal disease, shock, and hyperkalemia (BRASH) syndrome is a well-recognized constellation of distinct clinicopathologic entities comprising bradycardia, renal failure, AV nodal disease, shock, and hyperkalemia. Our patient is an 89-year-old female with a past medical history significant for hypertension and diabetes, who was newly started on labetalol and had recent gastroenteritis; she presented to our Emergency Department with bradycardia and shock. Upon presentation, she showed physical signs of volume depletion, and her blood pressure was 50 mmHg systolic and heart rate was 25 beats per minute. The initial electrocardiogram showed an idioventricular rhythm. The laboratory workup revealed hyperkalemia. The patient was given repeated doses of atropine with no significant response. She was resuscitated with isotonic fluids. The patient improved clinically, her blood pressure stabilized, her potassium level, renal function, and heart rate were normalized, and normal sinus rhythm was restored with a narrow QRS complex. A diagnosis of BRASH syndrome was made retrospectively. Overall, the treatment of this syndrome is largely symptomatic. Hemodynamic support with fluid and treatment of hyperkalemia remains the goal of care. The overall prognosis is good if identified early and managed appropriately.

Indexed as

av nodal diseasebradycardiabrash syndromehyperkalemiarenal failure

Identifiers

PMID36620804
PMCPMC9812229
OpenAlexW4311624378

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.